Mitochondrial Protection by the Mixed Muscarinic/Sigma-1 Ligand ANAVEX2-73

ANAVEX® Life Sciences Corp.
Jan 20, 2015
1 min read

Mitochondrial protection by the mixed muscarinic/sigma-1 Ligand ANAVEX2-73, a tetrahydrofuran derivative, in Ab25—35 peptide-injected mice, a nontransgenic Alzheimer's disease model.

Frontiers in Cellular Neuroscience, Volume 8, Article 463 (January 20, 2015) Valentine Lahmy, Romain Long, Didier Morin, Vanessa Villard and Tangui Maurice

View Paper

Recent Posts

See All

Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group

Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’

Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program